在直接口服抗凝剂治疗的房颤患者中用血栓弹力图评估止血功能。 - Suppr | 超能文献

相似文献

1

Assessing the hemostasis with thromboelastometry in direct oral anticoagulants-treated patients with atrial fibrillation.在直接口服抗凝剂治疗的房颤患者中用血栓弹力图评估止血功能。

Thromb Res. 2020 Jul;191:38-41. doi: 10.1016/j.thromres.2020.04.038. Epub 2020 Apr 28.

2

New oral anticoagulants for patients with nonvalvular atrial fibrillation.用于非瓣膜性心房颤动患者的新型口服抗凝剂。

JAAPA. 2015 Nov;28(11):28-34. doi: 10.1097/01.JAA.0000471615.92278.1c.

3

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants.不同直接口服抗凝药物治疗的老年非瓣膜性心房颤动患者转换为另一种口服抗凝药物和停药情况。

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619870249. doi: 10.1177/1076029619870249.

4

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.比较 CMS 医疗保险人群中老年非瓣膜性心房颤动患者使用直接口服抗凝剂与华法林的临床结局。

J Thromb Thrombolysis. 2019 Aug;48(2):240-249. doi: 10.1007/s11239-019-01838-5.

5

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.非瓣膜性心房颤动患者口服抗凝药的安全性和有效性比较：NAXOS 研究。

Stroke. 2020 Jul;51(7):2066-2075. doi: 10.1161/STROKEAHA.120.028825. Epub 2020 Jun 16.

6

Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.伴有单一卒中危险因素的房颤患者中标准剂量非维生素 K 拮抗剂口服抗凝剂和华法林的有效性和安全性：一项全国性队列研究。

JAMA Cardiol. 2017 Aug 1;2(8):872-881. doi: 10.1001/jamacardio.2017.1883.

7

Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation.阿哌沙班与利伐沙班治疗心房颤动患者的有效性和安全性

Ann Intern Med. 2020 Apr 7;172(7). doi: 10.7326/P20-0003. Epub 2020 Mar 10.

8

[New oral anticoagulants in patients with atrial fibrillation in a urban health center].[城市医疗中心心房颤动患者的新型口服抗凝剂]

Med Clin (Barc). 2016 Mar 18;146(6):280-1. doi: 10.1016/j.medcli.2015.06.016. Epub 2015 Sep 4.

9

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.与华法林相比，直接口服Xa因子抑制剂在病态肥胖患者中的疗效和安全性：一项单中心图表数据回顾性分析

Lancet Haematol. 2019 Jul;6(7):e359-e365. doi: 10.1016/S2352-3026(19)30086-9. Epub 2019 May 24.

10

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies.非维生素 K 拮抗剂口服抗凝剂在非瓣膜性心房颤动中预防卒中的直接比较有效性和安全性：观察性研究的系统评价和荟萃分析。

Eur J Epidemiol. 2019 Feb;34(2):173-190. doi: 10.1007/s10654-018-0415-7. Epub 2018 Jun 8.

引用本文的文献

1

"In Less than No Time": Feasibility of Rotational Thromboelastometry to Detect Anticoagulant Drugs Activity and to Guide Reversal Therapy.“转眼间”：旋转血栓弹力图检测抗凝药物活性及指导逆转治疗的可行性

J Clin Med. 2022 Mar 4;11(5):1407. doi: 10.3390/jcm11051407.